FTPR12

Nom de l'organisation

Labomar S.p.A.

SRN

IT-MF-000007965

Statut du fabricant

Actif

Santé des certificats sur le portefeuille de ce fabricant.

5 avertissements enregistrés — faire défiler le panneau pour tout voir.

• CW010

  EUDAMED n'a pas publié de description pour ce code.
• CW007

  EUDAMED n'a pas publié de description pour ce code.
• CW032

  EUDAMED n'a pas publié de description pour ce code.
• CW135

  EUDAMED n'a pas publié de description pour ce code.
• CW999

  Before administering to children under three years of age, it is recommended that you seek the advice of your doctor. If you do not notice appreciable results after a short period of treatment (7 days), contact your doctor, in any case do not use for more than 15 days. Do not take it if you are allergic, intolerant or hypersensitive to any component. Do not use for purposes other than that for which the product is intended. No side effects associated by used the device have been observed. If you notice the appearance of side effects, inform your doctor. Any serious incident that has occurred in relation to the device should be reported to the manufacturer and the Competent Authority. In case of any undesired event always seek medical advice. Expiry date refers to the product in its intact packaging, and properly stored. Since no data on use during pregnancy and lactation are available, its use is generally not recommended as a precaution due to lack of experimental data. Even if no side effects are known, it is recommended not to use the product during pregnancy or breastfeeding. In any case, consult your doctor before taking it. In the event of concomitant pharmacological treatment, although no interactions with drugs are known, it is advisable to consult a doctor before use. Do not exceed the recommended daily dose.

Marché principal en Pays-Bas ; disponible dans 2 pays au total.

Dénomination commerciale

non renseigné

Code d'UDI-DI

08056300621805

Basic UDI-DI

805630062FTPR1297

Numéro de référence/catalogue

FTPR12

Entité d'attribution

GS1

Catégorie de risque

Classe IIa

Législation applicable

MDR [Règlement (UE) 2017/745 relatif aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

SPRAY GOLA FAMILY is a medical device composed of substances, non-sterile, intended for short term invasive contact with respect to body orifices (oral cavity), designed for the treatment of sore throat in adult and children (2+).

URL des informations complémentaires

https://labomar.com/en/products/ftpr-12-2/

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• V9017ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES